-
1
-
-
79955835059
-
Pathogenesis of non-Hodgkin's lymphoma
-
Nogai H, Dörken B, Lenz G (2011) Pathogenesis of non-Hodgkin's lymphoma. J Clin Oncol 29(14):1803-1811.
-
(2011)
J Clin Oncol
, vol.29
, Issue.14
, pp. 1803-1811
-
-
Nogai, H.1
Dörken, B.2
Lenz, G.3
-
2
-
-
0034598746
-
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
-
Alizadeh AA, et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769):503-511.
-
(2000)
Nature
, vol.403
, Issue.6769
, pp. 503-511
-
-
Alizadeh, A.A.1
-
3
-
-
33344454909
-
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
-
Pasqualucci L, et al. (2006) Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 203(2):311-317.
-
(2006)
J Exp Med
, vol.203
, Issue.2
, pp. 311-317
-
-
Pasqualucci, L.1
-
4
-
-
33646569453
-
Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas
-
Tam W, et al. (2006) Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood 107(10):4090-4100.
-
(2006)
Blood
, vol.107
, Issue.10
, pp. 4090-4100
-
-
Tam, W.1
-
5
-
-
52649102382
-
Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression
-
Schmidlin H, et al. (2008) Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression. Blood 112(5):1804-1812.
-
(2008)
Blood
, vol.112
, Issue.5
, pp. 1804-1812
-
-
Schmidlin, H.1
-
6
-
-
33845501828
-
Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival
-
Uddin S, et al. (2006) Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood 108(13):4178-4186.
-
(2006)
Blood
, vol.108
, Issue.13
, pp. 4178-4186
-
-
Uddin, S.1
-
7
-
-
77951693077
-
High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
-
Hasselblom S, et al. (2010) High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Br J Haematol 149(4):560-568.
-
(2010)
Br J Haematol
, vol.149
, Issue.4
, pp. 560-568
-
-
Hasselblom, S.1
-
8
-
-
0033551070
-
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
-
Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96(8):4240-4245.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, Issue.8
, pp. 4240-4245
-
-
Cantley, L.C.1
Neel, B.G.2
-
9
-
-
79551542888
-
PTEN level in tumor suppression: How much is too little?
-
Carracedo A, Alimonti A, Pandolfi PP (2011) PTEN level in tumor suppression: How much is too little? Cancer Res 71(3):629-633.
-
(2011)
Cancer Res
, vol.71
, Issue.3
, pp. 629-633
-
-
Carracedo, A.1
Alimonti, A.2
Pandolfi, P.P.3
-
10
-
-
33845999615
-
Essential role for nuclear PTEN in maintaining chromosomal integrity
-
Shen WH, et al. (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128(1):157-170.
-
(2007)
Cell
, vol.128
, Issue.1
, pp. 157-170
-
-
Shen, W.H.1
-
11
-
-
78651482046
-
Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner
-
Song MS, et al. (2011) Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 144(2):187-199.
-
(2011)
Cell
, vol.144
, Issue.2
, pp. 187-199
-
-
Song, M.S.1
-
12
-
-
84860217431
-
The functions and regulation of the PTEN tumour suppressor
-
Song MS, Salmena L, Pandolfi PP (2012) The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13(5):283-296.
-
(2012)
Nat Rev Mol Cell Biol
, vol.13
, Issue.5
, pp. 283-296
-
-
Song, M.S.1
Salmena, L.2
Pandolfi, P.P.3
-
13
-
-
73849145729
-
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
-
Davis RE, et al. (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463(7277):88-92.
-
(2010)
Nature
, vol.463
, Issue.7277
, pp. 88-92
-
-
Davis, R.E.1
-
14
-
-
51649111684
-
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
-
Lenz G, et al. (2008) Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 105(36):13520-13525.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, Issue.36
, pp. 13520-13525
-
-
Lenz, G.1
-
15
-
-
0032212223
-
PTEN gene alterations in lymphoid neoplasms
-
Sakai A, Thieblemont C, Wellmann A, Jaffe ES, Raffeld M (1998) PTEN gene alterations in lymphoid neoplasms. Blood 92(9):3410-3415.
-
(1998)
Blood
, vol.92
, Issue.9
, pp. 3410-3415
-
-
Sakai, A.1
Thieblemont, C.2
Wellmann, A.3
Jaffe, E.S.4
Raffeld, M.5
-
16
-
-
0032968603
-
Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas
-
Butler MP, Wang SI, Chaganti RS, Parsons R, Dalla-Favera R (1999) Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas. Genes Chromosomes Cancer 24(4):322-327.
-
(1999)
Genes Chromosomes Cancer
, vol.24
, Issue.4
, pp. 322-327
-
-
Butler, M.P.1
Wang, S.I.2
Chaganti, R.S.3
Parsons, R.4
Dalla-Favera, R.5
-
17
-
-
0032100506
-
Alterations of the MMAC1/PTEN gene in lymphoid malignancies
-
Grønbaek K, Zeuthen J, Guldberg P, Ralfkiaer E, Hou-Jensen K (1998) Alterations of the MMAC1/PTEN gene in lymphoid malignancies. Blood 91(11):4388-4390.
-
(1998)
Blood
, vol.91
, Issue.11
, pp. 4388-4390
-
-
Grønbaek, K.1
Zeuthen, J.2
Guldberg, P.3
Ralfkiaer, E.4
Hou-Jensen, K.5
-
18
-
-
0034671221
-
Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor
-
Georgescu MM, et al. (2000) Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Res 60(24):7033-7038.
-
(2000)
Cancer Res
, vol.60
, Issue.24
, pp. 7033-7038
-
-
Georgescu, M.M.1
-
19
-
-
20444479428
-
C-Myc-regulated microRNAs modulate E2F1 expression
-
O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435(7043):839-843.
-
(2005)
Nature
, vol.435
, Issue.7043
, pp. 839-843
-
-
O'Donnell, K.A.1
Wentzel, E.A.2
Zeller, K.I.3
Dang, C.V.4
Mendell, J.T.5
-
20
-
-
39749163245
-
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
-
Xiao C, et al. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9(4):405-414.
-
(2008)
Nat Immunol
, vol.9
, Issue.4
, pp. 405-414
-
-
Xiao, C.1
-
21
-
-
77949900650
-
Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice
-
Kharas MG, et al. (2010) Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice. Blood 115(7):1406-1415.
-
(2010)
Blood
, vol.115
, Issue.7
, pp. 1406-1415
-
-
Kharas, M.G.1
-
22
-
-
33645292598
-
A library of gene expression signatures to illuminate normal and pathological lymphoid biology
-
Shaffer AL, et al. (2006) A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev 210:67-85.
-
(2006)
Immunol Rev
, vol.210
, pp. 67-85
-
-
Shaffer, A.L.1
-
23
-
-
23244460597
-
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
-
Chen Z, et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436(7051):725-730.
-
(2005)
Nature
, vol.436
, Issue.7051
, pp. 725-730
-
-
Chen, Z.1
-
24
-
-
80051680291
-
A continuum model for tumour suppression
-
Berger AH, Knudson AG, Pandolfi PP (2011) A continuum model for tumour suppression. Nature 476(7359):163-169.
-
(2011)
Nature
, vol.476
, Issue.7359
, pp. 163-169
-
-
Berger, A.H.1
Knudson, A.G.2
Pandolfi, P.P.3
-
25
-
-
57149089307
-
Stromal gene signatures in large-B-cell lymphomas
-
Lenz G, et al. (2008) Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359(22):2313-2323.
-
(2008)
N Engl J Med
, vol.359
, Issue.22
, pp. 2313-2323
-
-
Lenz, G.1
-
26
-
-
34547524771
-
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
-
Meng F, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133(2):647-658.
-
(2007)
Gastroenterology
, vol.133
, Issue.2
, pp. 647-658
-
-
Meng, F.1
-
27
-
-
77953957633
-
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
-
Poliseno L, et al. (2010) A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465(7301):1033-1038.
-
(2010)
Nature
, vol.465
, Issue.7301
, pp. 1033-1038
-
-
Poliseno, L.1
-
28
-
-
84865114403
-
Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis
-
Sander S, et al. (2012) Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell 22(2):167-179.
-
(2012)
Cancer Cell
, vol.22
, Issue.2
, pp. 167-179
-
-
Sander, S.1
-
29
-
-
84867051939
-
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
-
Schmitz R, et al. (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490(7418):116-120.
-
(2012)
Nature
, vol.490
, Issue.7418
, pp. 116-120
-
-
Schmitz, R.1
-
30
-
-
33747605773
-
Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias
-
Malempati S, et al. (2006) Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias. Leukemia 20(9):1572-1581.
-
(2006)
Leukemia
, vol.20
, Issue.9
, pp. 1572-1581
-
-
Malempati, S.1
-
31
-
-
79959248268
-
Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia
-
Bonnet M, et al. (2011) Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia. Blood 117(24):6650-6659.
-
(2011)
Blood
, vol.117
, Issue.24
, pp. 6650-6659
-
-
Bonnet, M.1
-
32
-
-
71249122797
-
Coexpression of CD44 variant isoforms and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status-independent predictor of poor outcome in diffuse large B-cell lymphomas
-
Nagel S, Hirschmann P, Dirnhofer S, Günthert U, Tzankov A (2010) Coexpression of CD44 variant isoforms and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status-independent predictor of poor outcome in diffuse large B-cell lymphomas. Exp Hematol 38(1): 38-45.
-
(2010)
Exp Hematol
, vol.38
, Issue.1
, pp. 38-45
-
-
Nagel, S.1
Hirschmann, P.2
Dirnhofer, S.3
Günthert, U.4
Tzankov, A.5
-
33
-
-
79951990286
-
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab
-
Meyer PN, et al. (2011) Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol 29(2):200-207.
-
(2011)
J Clin Oncol
, vol.29
, Issue.2
, pp. 200-207
-
-
Meyer, P.N.1
-
34
-
-
79951958340
-
A robust immunohistochemical assay for detecting PTEN expression in human tumors
-
Sangale Z, et al. (2011) A robust immunohistochemical assay for detecting PTEN expression in human tumors. Appl Immunohistochem Mol Morphol 19(2):173-183.
-
(2011)
Appl Immunohistochem Mol Morphol
, vol.19
, Issue.2
, pp. 173-183
-
-
Sangale, Z.1
-
35
-
-
84878907241
-
MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma
-
Wenzel SS, et al. (2013) MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma. Leukemia 27(6):1381-1390.
-
(2013)
Leukemia
, vol.27
, Issue.6
, pp. 1381-1390
-
-
Wenzel, S.S.1
|